Prenatal Testing & Newborn Screening Market By Type 2023 | IndustryARC
  • 1-614-588-8538 (Ext: 101)
  • US Toll Free

Prenatal Testing & Newborn Screening Market
Prenatal Testing & Newborn Screening Market: By Type (Screening & Diagnosis Tests); Technology (Tandem Mass Spectroscopy, Electrophoresis, Enzyme & Immuno Assays, DNA Based Assays); Instrument (Hearing Screen, Reagents, Assay Kits, Ultrasonography, Others) & By Geography – Forecast (2018-2023)
Report Code : HCR 0081
Updated Date: 29 March, 2018  
4

Copies sold

    Client Rating

  • Report Description
  • Table of Contents
  • Tables And Figures
  • Customization Options
1. Market Overview
2. Executive Summary
3. Prenatal Testing & Newborn Screening Market Landscape
   3.1. Market Share Analysis
   3.2. Comparative Analysis
      3.2.1. Product Benchmarking
      3.2.2. End User Profiling
      3.2.3. Top 5 Financials Analysis
4. Prenatal Testing & Newborn Screening Market-Forces
   4.1. Market Drivers
   4.2. Market Constraints & Challenges
      4.2.1. Power suppliers
      4.2.2. Threats from new entrants
      4.2.3. Power Buyer 
      4.2.4. Threat from substitute product
      4.2.5. Degree Competition
5. Prenatal Testing & Newborn Screening Market-Strategic Analysis 
   5.1. Prenatal Testing Newborn Screening Market - Value Chain Analysis 
   5.2. Pricing Analysis 
   5.3. Opportunity Analysis
   5.4. Product Life Cycle 
   5.5. Suppliers Distributors 
   5.6. SWOT Analysis
6. Prenatal Testing & Newborn Screening Market by Types
   6.1. Introduction 
   6.2. Screening Tests
   6.3. Diagnosis Tests
7. Prenatal Testing Newborn Screening Market by Diagnosing Technique
   7.1. Introduction
   7.2. Non Invasive
      7.2.1. Ultrasonography 
      7.2.2. Pre-implementation Genetic Diagnosis
      7.2.3. Fetal Cells in Maternal Circulation
      7.2.4. Fetus-Free Fetal DNA 
   7.3. Invasive 
      7.3.1. Amniocentesis
      7.3.2. CVS
      7.3.3. Fetal blood sampling
      7.3.4. Embryoscopy & Fetoscopy
8. Prenatal Testing & Newborn Screening Market by Screening Options
   8.1. Introduction 
   8.2. First Trimester
      8.2.1. Nuclear Translucency (NT)
      8.2.2. Serum Screening
   8.3. Second Trimester
      8.3.1. Triple Screen
      8.3.2. Quadruple Screen
      8.3.3. Genetic Sonograms
      8.3.4. Extended Sonogram
   8.4. Third Trimester 
      8.4.1 Group B streptococcus screening
      8.4.2 Electronic fetal heart monitoring
      8.4.3 Contraction stress test
      8.4.4 Non-stress test
   8.5. Sequential Screening
   8.6. Ultrasonography
9. Prenatal Testing & Newborn Screening Market by Technology
   9.1. Tandem Mass Spectrometry
   9.2. Electrophoresis
   9.3. Enzymes and Immuno Assays
   9.4. DNA Based Assays
   9.5. Pulse Oximetry Technology
   9.6. Hearing Screen Technology
10. Prenatal Testing Newborn Screening Market by Instruments 
   10.1. Hearing screen instruments
   10.2. Reagent Assay Kits
   10.3. Ultrasonography
   10.4 Tandem Quadrupole Detector
   10.5 Incubator Shaker
   10.6 Others
11. Prenatal Testing Newborn Screening Market by Geography 
   11.1. North America 
      11.1.1. U.S. 
      11.1.2 Canada 
      11.1.3. Mexico 
   11.2. South America 
      11.2.1. Brazil 
      11.2.2. Venezuela
      11.2.3. Argentina
      11.2.4. Ecuador
      11.2.5. Peru
      11.2.6. Colombia 
      11.2.7. Costa Rica
   11.3. Europe 
      11.3.1. U.K 
      11.3.2. Germany 
      11.3.3. Italy 
      11.3.4. France
      11.3.5. Netherlands
      11.3.6. Belgium
      11.3.7. Spain 
   11.4. APAC
      11.4.1. China 
      11.4.2. Australia 
      11.4.3. South Korea
      11.4.4. India
      11.4.5. Taiwan
      11.4.6. Malaysia
      11.4.7. Hong Kong 
   11.5. Middle East& Africa 
   11.6. Russia
   11.7. Israel
   11.8. Other
12. Prenatal Testing Newborn Screening Market Market-Entropy
13. Company Profiles
   13.1. 23 and Me
   13.2. Abbott 
   13.3. Agilent technologies
   13.4. Babycentr llc
   13.6. Bio-Rad
   13.7. Color Genomics
   13.8. CRISPR
   13.9. Edinberg Genomics
   13.10. Editas Medicine
   13.11. Eurofins scientific
   13.12. Company 12
   13.13. Company 13
   13.14. Company 14
   13.15. Company 15
*More than 10 Companies are profiled in this Research Report*
"*Financials would be provided on a best efforts basis for private companies"
14. Appendix
   14.1. Abbreviations
   14.2. Sources
   14.3. Research Methodology
   14.4. Expert Insight
According to the United Nations statistics, more than 131 million babies are born each year across the world. In addition, approximately 8 million are born with birth defects. Prenatal Testing and Newborn Screening is one of the advanced techniques used in the healthcare industry to identify the defects at a very early stage. The employment of these tests has been growing tremendously to identify any birth defects in early stages. 

The hearing screen instruments had a major share in the instruments segment with a market share of 28%. The growth in prenatal and newborn genetic testing market is majorly driven by awareness of various genetic and chromosomal disorders which can be screened with the help of advanced instruments and further course of action can be planned accordingly. The development of various healthcare technologies such as next generation sequencing, high throughput screening has helped to detect various abnormalities at an early stage. These tests are expected to grow at CAGR of 10.8% during the forecast period i.e. 2018-2023. 

What is Prenatal testing and Newborn screening?
Prenatal diagnosis is a series of tests conducted during pregnancy to determine the health of the fetus at an early stage. These tests can determine various genetic and chromosomal anomalies such as birth defects, gene mutations, cystic fibrosis and so on. The purpose of prenatal diagnosis is the early detection of abnormal diseases so that a suitable treatment can be advised.

Newborn screening is the test carried out during the early days of the babies for detection of certain disorders which would hinder their growth and development. Various abnormalities such as phenylketonuria (PKU), galactosemia, sickle cell disease, congenital hypothyroidism are detected during these tests.

The report incorporates in-depth analysis of prenatal testing and newborn screening market by type, diagnostic techniques, technology, instruments and geography.

What are the major applications of Prenatal testing and Newborn screening?
Prenatal testing and newborn screening tests help to determine various genetic and chromosomal diseases. Genetic diseases such as sickle cell, down’s syndrome, cystic fibrosis and muscular dystrophy are detected with the help of these tests. It helps to provide timely medical or surgical treatment of a condition before or after birth. These tests also provide a chance to abort the fetus in case it has been diagnosed with a deadly disorder. It helps parents to prepare psychologically, socially, financially, and medically for a baby with a health problem. In some cases, extremely rare diseases can also be detected.

Prenatal Testing & Newborn Screening Market

Market Research and Market Trends of Prenatal testing and Newborn screening:
  • In 2016, Eurofins LifeCodexx launched the first noninvasive prenatal test (NIPT) assay based on a quantitative real-time PCR for prenatal testing of fetal trisomy 21. This test is cost effective and has faster processing time when compared to the conventional PCR technique. Hence, it is widely used in molecular diagnostics as the test results are of highest quality standards. In 2017, Eurofins Genoma enhanced the NIPT technology that screens for both de novo – gene mutations, that are not inherited – and inherited single-gene disorders through simple blood tests.
  • Approximately 60 to 65 percent of the prenatal genetic tests are now switching to next-generation sequencing (NGS) methodologies. Emergence of NGS along with various microarray techniques provides a wider scope to create tests with better specificity and sensitivity. GeneVu, a product of Roche Holding AG uses next-generation sequencing to detect mutations and carriers during prenatal testing.
  • Whole-Exome Sequencing (WES) is analysis of all exons of all protein coding genes in the human genome. WES is a less costly and more efficient method in detecting mutations. However, WGS is useful as it analyzes around 3 billion base pairs and is more powerful than WES. At present, WGS is much more expensive than WES because of its sequencing technology and requires a large database to store, manage and analyze the data. WGS has been improving at a very fast rate and with the reduction in cost, it would be highly preferred over WES in clinical practice. 
  • Qiagen, which solely focused on oncology has shifted its focus in the development of fetal cell-free DNA assays for prenatal testing technology. Pregnant mothers can undergo non-invasive prenatal testing to prevent birth defects in babies. This technology differentiates the fetal placental DNA from the background of the mother’s DNAs, further giving detail insight to the doctors pertaining to baby’s genetic issues.

Who are the Major Players in Prenatal testing and Newborn screening market?
The companies referred to in this market research report include Abbott laboratories, Thermo fisher Scientific, Qaigen, Bio-Rad, Strand life sciences, Roche Holding AG, Eurofins scientific, Natera Inc., Premaitha Health plc, Illumina, Inc., Quest diagnostics Inc.

What is our report scope?
The report incorporates in-depth assessment  the competitive landscape, product market sizing, product benchmarking, market trends, product developments, financial analysis, strategic analysis  so on to gauge the impact forces  potential opportunities  the market. Apart from this the report also includes a study  major developments in the market such as product launches, agreements, acquisitions, collaborations, mergers  so on to comprehend the prevailing market dynamics at present  its impact during the forecast period 2018-2024.

All our reports are customizable to your company needs to a certain extent, we do provide 20 free consulting hours along with purchase each report and this will allow you to request any additional data to customize the report to your needs.

Key Takeaways from this Report
  • Evaluate market potential through analyzing growth rates (CAGR %), Volume (Units) Value ($M) data given at country level – for product types, end use applications by different industry verticals.
  • Understand the different dynamics influencing the market – key driving factors, challenges hidden opportunities.
  • Get in-depth insights on your competitor performance – market shares, strategies, financial benchmarking, product benchmarking, SWOT more.
  • Analyze the sales distribution channels across key geographies to improve top-line revenues.
  • Understand the industry supply chain with a deep-dive on the value augmentation at each step, in order to optimize value bring efficiencies in your processes. 
  • Get a quick outlook on the market entropy – M&A’s, deals, partnership and product launches all key players for the past 4 years. 
  • Evaluate the supply-dem gaps, import-export statistics  regulatory  lscape for more than top 20 countries globally for the market
LIST OF TABLES:

Table 1: Global Prenatal Testing and Newborn Screening Market, Competitor Benchmarking
Table 2: Global: Prenatal Testing Market by Types, (2016-2022), $Million 
Table 3: Prenatal Testing Market Revenue, By Diagnosing Technique, 2016-2022 ($Million)
Table 4: Prenatal Testing Market, By Screening Options, 2016-2022 ($Million)
Table 5: Prenatal Testing Market, By First Trimester, 2016-2022 ($Million)
Table 6: Prenatal Testing Market, By Second Trimester, 2016-2022 ($Million)
Table 7: Global Newborn Screening Market Value, By Technology (2016-2022), $Million 
Table 8: Global Prenatal Testing Market Value, By Geography, 2016-2022 ($Million)
Table 9: Global Newborn Screening Market Value, By Geography, 2016-2022 ($Million)
Table 10: America: Prenatal testing Market Value, By Country, 2016-2022 ($Million)
Table 11: America: Prenatal testing Market Value, By Type, 2016-2022 ($Million): 
Table 12: America: Prenatal testing Market Value, By Diagnosing Technique, 2016-2022 ($Million)
Table 13: America: Prenatal Testing Market Value, By Screening Options, 2016-2022 ($Million): 
Table 14: U.S.: GDP – Composition of 2016, By End Use
Table 15: Canada: GDP – Composition of 2016, By End Use
Table 16: Mexico: GDP – Composition of 2016, By End Use
Table 17: Brazil: GDP – Composition of 2016, By End Use
Table 18: Europe Prenatal Testing Market Revenue, By Country 2016-2022 ($Million): 
Table 19: Europe Prenatal Testing Market Revenue, By Types, 2016-2022 ($Million) 
Table 20: Europe Prenatal Testing Market Revenue, By Diagnosis Techniques, 2016-2022 ($Million) 
Table 21: Europe Prenatal Testing Market Revenue, By Screening Options, 2016-2022 ($Million)
Table 22: U.K.: GDP – Composition of 2016, By End Use
Table 23: Germany: GDP – Composition of 2016, By End Use
Table 24: France: GDP – Composition of 2016, By End Use
Table 25: APAC Prenatal Testing Market Revenue, By Geography, 2016-2022 ($Million) 
Table 26: APAC Prenatal Testing Market Revenue, By Types, 2016-2022 ($Million) 
Table 27: APAC Prenatal Testing Market Revenue, By Diagnosing Technique, 2016-2022 ($Million) 
Table 28: Prenatal & Newborn Testing Market Revenue, By Screening Options, 2016-2022 ($Million) 
Table 29: China: GDP – Composition of 2015, By End Use
Table 30: Japan: GDP – Composition of 2016, By End Use
Table 31: India: GDP – Composition of 2016, By End Use
Table 32: RoW Prenatal Testing Market Value, By Country, 2016-2022 ($Million) 
Table 33: RoW Prenatal Testing Market Value, By Type, 2016-2022 ($Million) 
Table 34: RoW Prenatal Testing Market Value, By Diagnosing Technique, 2016-2022 ($Million) 
Table 35: RoW Prenatal Testing Market Value, By Screening Options, 2016-2022 ($Million)


LIST OF FIGURES:

Figure 1: Global Prenatal Testing Market Value 2016-2022, ($Million)
Figure 2: Global Newborn Screening Market Value 2016-2022, ($Million)
Figure 3: Global Prenatal Testing Market Value, By Type, 2016-2022, ($Million)
Figure 4: Global Prenatal Testing Market Value, By Technique, 2016-2022, ($Million)
Figure 5: Global Newborn Screening Market Share, By Region, 2016 (%)Global Prenatal Testing and Newborn Screening Market Revenue Share, By Company, 2016 (%)
Figure 6: Prenatal Testing and Newborn Screening Patents, By Year, 2013-2017
Figure 7: Prenatal Testing and Newborn Screening Patents, By Geography (%)
Figure 8: Prenatal Testing Patents, By Company (%)
Figure 9: Newborn Screening Patents, By Company (%)
Figure 10: F. Hoffmann-La Roche Ltd: 
Figure 11: Abbott Laboratories
Figure 12: Beckman Coulter, Inc.
Figure 13: Thermo Fisher Scientific: 
Figure 14: Siemens Ltd.
Figure 15: EPS, By Company, 2015 ($)
Figure 16: Prenatal Testing Life Cycle, (2016 - 2022)
Figure 17: Suppliers and distributors
Figure 18: Screening Tests: Prenatal Testing Market Revenue, 2016-2022 ($Million)
Figure 19: Diagnosis Tests: Prenatal Testing Market Revenue, 2016-2022 ($Million)
Figure 20: Non-Invasive: Prenatal Testing Market Revenue, By Diagnosing Technique, 2016-2022 ($Million)
Figure 21: Ultrasonography: Prenatal Testing Market Revenue, By Diagnosing Technique, 2016-2022 ($Million)
Figure 22: Preimplantation Genetic Diagnosis: Prenatal Testing Market Revenue, By Diagnosing Technique, 2016-2022 ($Million)
Figure 23: Fetal Cells in Maternal Circulation: Prenatal Testing Market Revenue, By Diagnosing Technique, 2016-2022 ($Million)
Figure 24: Fetus-Free Fetal DNA: Prenatal Testing Market Revenue, By Diagnosing Technique, 2016-2022 ($Million)
Figure 25: Invasive: Prenatal Testing Market Revenue, By Diagnosing Technique, 2016-2022 ($Million)
Figure 26: Amniocentesis: Prenatal Testing Market Revenue, By Diagnosing Technique, 2016-2022 ($Million)
Figure 27: CVS: Prenatal Testing Market Revenue, By Diagnosing Technique, 2016-2022 ($Million)
Figure 28: Fetal Blood Sampling: Prenatal Testing Market Revenue, By Diagnosing Technique, 2016-2022 ($Million)
Figure 29: Embryoscopy & Fetoscopy: Prenatal Testing Market Revenue, By Diagnosing Technique, 2016-2022 ($Million)
Figure 30: Nuchal Translucency: Prenatal testing Market Revenue, 2016 - 2022 ($Million)
Figure 31: Serum Screening: Prenatal testing Market Revenue, 2016 - 2022 ($Million)
Figure 32: Triple Screen: Prenatal testing Market Revenue, 2016 - 2022 ($Million)
Figure 33: Quadruple Screen: Prenatal testing Market Revenue, 2016 - 2022 ($Million)
Figure 34: Genetic Sonogram: Prenatal testing Market Revenue, 2016 - 2022 ($Million)
Figure 35: Extended Sonogram: Prenatal testing Market Revenue, 2016 - 2022 ($Million)
Figure 36: Sequential Screening: Prenatal testing Market Revenue, 2016 - 2022 ($Million)
Figure 37: Ultrasonography: Prenatal testing Market Revenue, 2016 - 2022 ($Million)
Figure 38: Tandem Mass Spectrometry: Newborn Screening Market Revenue, 2016-2022 ($Million)
Figure 39: Electrophoresis: Newborn Screening Market Revenue, 2016-2022 ($Million)
Figure 40: Enzymes Immunoassays: Newborn Screening Market Revenue, 2016-2022 ($Million)
Figure 41: DNA Based Assays: Newborn Screening Market Revenue, 2016-2022 ($Million)
Figure 42: Pulse Oximetry Technology: Newborn Screening Market Revenue, 2016-2022 ($Million)
Figure 43: Hearing Screen Technology: Newborn Screening Market Revenue, 2016-2022 ($Million)
Figure 44: U.S.: GDP and Population, 2013-2016 ($Trillion, Million)
Figure 45: U.S.: GDP – Composition of 2016, By Sector of Origin
Figure 46: U.S.: Export and Import Value, 2013-2016 ($Trillion)
Figure 47: Number of Births in Millions (2011-2015)
Figure 48: U.S.:  Prenatal Testing Market Value, By Geography, 2016-2022 ($Million)
Figure 49: Canada: GDP and Population, 2013-2016 ($Trillion, Million)
Figure 50: Canada: GDP – Composition of 2016, By Sector of Origin
Figure 51: Canada: Export and Import Value, 2013-2016 ($Billion)
Figure 52: Number of Births in Canada from 2011/2012 to 2016/2017
Figure 53: Canada:  Prenatal Testing Market Value, By Geography, 2016-2022 ($Million)
Figure 54: Mexico: GDP and Population, 2013-2016 ($Trillion, Million)
Figure 55: Mexico: GDP – Composition of 2016, By Sector of Origin
Figure 56: Mexico: Export and Import Value, 2013-2016 ($Billion)
Figure 57: Fertility rate in Mexico from 2011-2015
Figure 58: Mexico: Prenatal Testing Market Value, By Geography, 2016-2022 ($Million)
Figure 59: Brazil: GDP and Population, 2013-2016 ($Trillion, Million)
Figure 60: Brazil: GDP – Composition of 2016, By Sector of Origin
Figure 61: Brazil: Export and Import Value, 2013-2016 ($Billion)
Figure 62: Fertility rate from 2011-2015
Figure 63: Brazil: Prenatal Testing Market Revenue, By Geography, 2016-2022 ($Million)
Figure 64: Rest of Americas: Prenatal Testing Market Revenue, By Geography, 2016-2022 ($Million)
Figure 65: U.K.: GDP and Population, 2013-2016 ($Trillion, Million)
Figure 66: U.K.: GDP – Composition of 2016, By Sector of Origin
Figure 67: U.K.: Export and Import Value, 2013-2016 ($Billion)
Figure 68: Live Birth Rate in the U.K. (2000-2016), (per thousand population)
Figure 69: U.K.:  Prenatal Testing Market Revenue, 2016-2022 ($Million)
Figure 70: Germany: GDP and Population, 2013-2016 ($Trillion, Million)
Figure 71: Germany: GDP – Composition of 2016, By Sector of Origin
Figure 72: Germany: Export and Import Value, 2013-2016 ($Billion)
Figure 73: Fertility Rate in Germany (2005-2015)
Figure 74: Number of Live Births in Germany (2002-2016)
Figure 75: Germany: Prenatal Testing Market Revenue, 2016-2022 ($Million)
Figure 76: Fertility Rate, By Region in Italy, (2016)
Figure 77: Italy: Prenatal Testing Market Revenue, By Geography, 2016-2022 ($Million)
Figure 78: France: GDP and Population, 2013-2016 ($Trillion, Million)
Figure 79: France: GDP – Composition of 2016, By Sector of Origin
Figure 80: France: Export and Import Value, 2013-2016 ($Billion)
Figure 81: Fertility rate in France (2005-2015)
Figure 82: France: Prenatal Testing Market Revenue, By Geography, 2016-2022 ($Million)
Figure 83: Rest of Europe: Prenatal Testing Market Revenue, By Geography, 2016-2022 ($Million)
Figure 84: China: GDP and Population, 2013-2016 ($Trillion, Million)
Figure 85: China: GDP – Composition of 2016, By Sector of Origin
Figure 86: China: Export and Import Value, 2013-2016 ($Billion)
Figure 87: Population Growth in China (2004-2015)
Figure 88: China: Prenatal Testing Market Revenue, By Geography, 2016-2022 ($Million)
Figure 89: Number of Births in South Korea (2000-2016)
Figure 90: South Korea: Prenatal Testing Market Revenue, By Geography, 2016-2022 ($Million)
Figure 91: Japan: GDP and Population, 2013-2016 ($Trillion, Million)
Figure 92: Japan: GDP – Composition of 2016, By Sector of Origin
Figure 93: Japan: Export and Import Value, 2013-2016 ($Billion)
Figure 94: Infant Mortality Rate in Japan (2006-2016)
Figure 95: Japan: Prenatal Testing Market Revenue, By Geography, 2016-2022 ($Million)
Figure 96: India: GDP and Population, 2013-2016 ($Trillion, Million)
Figure 97: India: GDP – Composition of 2016, By Sector of Origin
Figure 98: India: Export and Import Value, 2013-2016 ($Billion)
Figure 99: Number of Home Births in India (2016)
Figure 100: India: Prenatal Testing Market Revenue, By Geography, 2016-2022 ($Million)
Figure 101: Rest of APAC: Prenatal Testing Market Revenue, By Geography, 2016-2022 ($Million)
Figure 102: Middle East:  Prenatal Testing Market Value, By Geography, 2016-2022 ($Million)
Figure 103: Africa:  Prenatal Testing Market Value, By Geography, 2016-2022 ($Million)
Figure 104: Masimo, Revenue ($Million), 2013-2016
Figure 105: Masimo, Revenue Share (%), By Geography, 2016
Figure 106: Revenue ($Billion), 2013-2016
Figure 107: Revenue Market Share (%), By Geography, 2016
Figure 108: Revenue Share (%), By Business Segment, 2016
Figure 109: Revenue ($Billion), 2013-2016
Figure 110: Revenue Share (%), By Geography, 2016
Figure 111: Revenue Share (%), By Business Segment, 2016
Figure 112: Revenue ($Billion), 2013-2016
Figure 113: Sales by Geography, 2016 (%)
Figure 114: Revenue ($Billion), 2013-2016
Figure 115: Market Share by Geography 2016 (%)
Figure 116: Revenue ($Billion), 2013-2016
Figure 117: Revenue Share, By Business Segment, 2016 (%)
Please select Licence
Single User Licence:
US $4250
Corporate User Licence:
US $6250
Related Reports
0px;">Scroll